Interfaith Medical Center

Brooklyn, New York 11238

1 studies enrolling now · 8 studies all time

What they study most

HIV Infections, Phase 1 Sickle Cell, SARS-CoV2 Infection, Sickle Cell Anemia, Sickle Cell Disease, Sickle ß0-Thalassemia

Studies at this site

• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease — Recruiting now
• Research Study Investigating How Well NDec Works in People With Sickle Cell Disease — Completed
• Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) — APPROVED_FOR_MARKETING
• A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia — Completed
• Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Study Of PF-04447943, Co-Administered With And Without Hydroxyurea, In Subjects With Stable Sickle Cell Disease — Completed
• Preventing Acute Chest Syndrome by Transfusion Feasibility Study — Completed
• THE IMPROVE TRIAL: Improving Pain Management and Outcomes With Various Strategies of Patient-Controlled Analgesia (PCA) — Stopped early
• Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA — Status unconfirmed